Karma Oncology is a specialist oncology clinical development company headquartered in Scotland with offices in Ireland, Netherlands and USA. We offer a complete range of development services from clinical development planning, protocol design and authoring, strategic country/site selection, regulatory submissions, through to clinical trial execution and reporting.
With Karma, experience makes the difference - Our team has successfully completed programs in a broad range of solid tumour and hematologic indications utilizing an array of different therapeutic approaches including immunotherapy and autologous cell therapy and CAR-T cell therapy.
Karma is flexible - We can provide selected individual services, and extend to full-service global CRO capabilities as the program needs expand. Our size allows us to be flexible, innovative and responsive to individual sponsor requirements and to adhere strictly to specified development timelines.
Karma is different - Our Project Managers have extensive oncology experience, our monitors are professional, mature 'career' CRAs - not trainees - and we have the lowest staff turnover in the industry (<5%). Many of our staff come from a nursing or medical background, and for international studies we use CRAs native to their country.